Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.41 |
| ▸ | RARB | P10826 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1244396 | 0.88 | TDP1 (0.48) | TDP1MAPK1RARBEPHX2HPGD | |
| SCHEMBL16340342 | 0.88 | TDP1 (0.58) | FDPSTDP1ALOX5LMNAMAPK1 | |
| SCHEMBL6857008 | 0.88 | TDP1 (0.58) | FDPSTDP1ALOX5LMNAMAPK1 | |
| SCHEMBL920141 | 0.86 | TDP1 (0.60) | TDP1LMNAMAPK1RARBEPHX2 | |
| SCHEMBL3430758 | 0.85 | MAPK1 (0.46) | FDPSTDP1ALOX5MAPK1GGPS1 | |
| SCHEMBL10608344 | 0.84 | RARB (0.50) | TDP1MAPK1RARBEPHX2HPGD | |
| SCHEMBL4762110 | 0.83 | KCNA3 (0.52) | FDPSTDP1ALOX5LMNAMAPK1 | |
| SCHEMBL7536898 | 0.83 | KCNA3 (0.52) | FDPSTDP1ALOX5LMNAMAPK1 | |
| SCHEMBL6872300 | 0.83 | FDPS (0.39) | FDPSTDP1ALOX5LMNAMAPK1 | |
| SCHEMBL3614168 | 0.81 | FDPS (0.43) | FDPSTDP1ALOX5LMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2597932-B1 | MANUFACTURING METHOD FOR ORGANIC LIGHT-EMITTING DEVICE | SUMITOMO CHEMICAL CO (JP) | 2021-04-14 | — | — | EP | disclosed |
| EP-2680672-B1 | METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2021-03-31 | — | — | EP | disclosed |
| EP-2485289-B1 | LAMINATED STRUCTURE, POLYMER, ELECTROLUMINESCENT ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2021-03-03 | — | — | EP | disclosed |
| EP-2605621-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD OF PRODUCING SAME | SUMITOMO CHEMICAL CO (JP) | 2020-07-15 | — | — | EP | disclosed |
| EP-2846374-B1 | Layered structure | SUMITOMO CHEMICAL CO (JP) | 2019-11-06 | — | — | EP | disclosed |
| EP-2692796-B1 | COMPOSITION | SUMITOMO CHEMICAL CO (JP) | 2019-07-10 | — | — | EP | disclosed |
| EP-2597933-B1 | MANUFACTURING METHOD FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2019-06-12 | — | — | EP | disclosed |
| EP-2518111-B1 | COMPOSITION AND LUMINESCENT ELEMENT OBTAINED USING SAME | SUMITOMO CHEMICAL CO (JP) | 2019-03-13 | — | — | EP | disclosed |
| US-9929369-B2 | Organic electroluminescent element and method for manufacturing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-03-27 | — | — | US | disclosed |
| EP-2503615-B1 | DEVICE, THIN FILM TRANSISTOR, METHOD FOR MANUFACTURING THE DEVICE AND METHOD FOR MANUFACTURING THE THIN FILM TRANSISTOR | PANASONIC CORP (JP) | 2017-11-08 | — | — | EP | disclosed |
| US-20080248220-A1 | Light-Emitting Material and Light-Emitting Device Using the Same | SUMITOMO CHEMICAL COMPANY,LIMITED | 2008-10-09 | — | — | US | disclosed |
| US-7208567-B2 | Polymer compound and polymer light emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-04-24 | — | — | US | disclosed |
| US-20070040164-A1 | Polymer complex compound and polymer light emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-02-22 | — | — | US | disclosed |
| US-6875895-B2 | Such as 1,4-bis(2-(4-bromophenyl)-2-phenylethenyl)-2-(2-ethylhexyloxy)-5 -methoxybenzene; for polymerization into a light-emitting material | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-04-05 | — | — | US | disclosed |
| US-20040002576-A1 | Polymer compound and polymer light emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-01-01 | — | — | US | disclosed |
| EP-1344788-A1 | Conjugated polymer comprising dibenzothiophene- or dibenzofuran-units and their use in polymer LEDs | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-09-17 | — | — | EP | disclosed |
| US-20030100786-A1 | Bis (diphenylvinyl) arene compound | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-05-29 | — | — | US | disclosed |
| EP-1288184-A1 | Bis(diphenylvinyl)arene compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-03-05 | — | — | EP | disclosed |
| US-20020122899-A1 | Polymeric fluorescent substance and polymer light-emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2002-09-05 | — | — | US | disclosed |
| EP-1213336-A2 | Polymeric fluorescent substance and polymer light-emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-06-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030100786-A1 | Bis (diphenylvinyl) arene compound | CBR1, AR, CYP1B1 | FDPS 3218/4885TDP1 1059/4885ALOX5 3121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.